Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli

The clinical relevance of in vitro synergistic activity of antibiotics for MDR Gram-negative infections: A systematic review

(2019) Konstantinos Z. Vardakas et al.   Journal of Global Antimicrobial Resistance

Antimicrobial treatment challenges in the era of carbapenem resistance

(2019) Anna Maria Peri et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

EFFICACY OF CEFTAZIDIME-AVIBACTAM IN MONOTHERAPY OR COMBINATION THERAPY AGAINST CARBAPENEM RESISTANT GRAM NEGATIVE ORGANISMS: A META-ANALYSIS

(2019) Lorenzo Onorato et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Monotherapy versus combination therapy for multidrug-resistant Gram-negative infections: Systematic Review and Meta-Analysis

(2019) Adrian Schmid et al.   Scientific Reports

Colistin does not potentiate ceftazidime-avibactam killing of carbapenem-resistant Enterobacteriaceae in vitro or suppress emergence of ceftazidime-avibactam resistance

(2018) Ryan K. Shields et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical Modeling

(2018) Cornelia B. Landersdorfer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial Activity of Human Simulated Epithelial Lining Fluid Concentrations of Ceftazidime-Avibactam Alone or in Combination with Amikacin Inhale (BAY41-6551) against Carbapenem-Resistant Pseudomonas aeruginosa and Klebsiella pneumoniae

(2018) Safa S. Almarzoky Abuhussain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Assessment and modelling of antibacterial combination regimens

(2018) G.G. Rao et al.   CLINICAL MICROBIOLOGY AND INFECTION

Effect of increasing meropenem MIC on the killing activity of meropenem in combination with amikacin or polymyxin B against MBL and KPC producing Enterobacter cloacae

(2018) Brandon Kulengowski et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates

(2018) Uthaibhorn Singkham-in et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro antimicrobial activity of imipenem plus amikacin or polymyxin B against carbapenem-resistant Pseudomonas aeruginosa isolates

(2018) Camila M. Wilhelm et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Polymyxin B and fosfomycin thwart KPC-producing Klebsiella pneumoniae in the hollow-fibre infection model

(2018) Zackery P. Bulman et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

OUP accepted manuscript

(2018)   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro synergy and postantibiotic effect of colistin combinations with meropenem and vancomycin against Enterobacteriaceae with multiple carbapenem resistance mechanisms

(2018) Branka Bedenić et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

(2018) Mical Paul et al.   LANCET INFECTIOUS DISEASES

Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

(2018) Evelina Tacconelli et al.   LANCET INFECTIOUS DISEASES

Effect of Porins and blaKPC Expression on Activity of Imipenem with Relebactam in Klebsiella pneumoniae: Can Antibiotic Combinations Overcome Resistance?

(2018) Gregory Balabanian et al.   Microbial Drug Resistance

Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae

(2018) María E. Pachón-Ibáñez et al.   Frontiers in Microbiology

Synergistic Activity of Colistin-Containing Combinations against Colistin-Resistant Enterobacteriaceae

(2018) Thea Brennan-Krohn et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Bactericidal Activity of Trimethoprim–Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

(2018) Jiachun Su et al.   Microbial Drug Resistance

Staggering the administration of polymyxin B and meropenem in time-kill against carbapenem-resistant Enterobacteriaceae exhibiting a wide range of meropenem MICs

(2018) Brandon Kulengowski et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model

(2018) Mahmoud A. F. Khalil et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis

(2018) Alessandro Cassini et al.   LANCET INFECTIOUS DISEASES

In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase–producing Klebsiella pneumoniae

(2018) Wenxia Zhang et al.   Antimicrobial Resistance and Infection Control

1385. Efficacy of Ceftazidime–Avibactam in Combination with Aztreonam (COMBINE): Solutions for Metallo-β-Lactamase Producing-Enterobacteriaceae (MBL)

(2018) Thomas P Lodise et al.   Open Forum Infectious Diseases

Pharmacodynamics of tigecycline alone and in combination with colistin against clinical isolates of multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model

(2017) Xuejiu Cai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changes

(2017) Rajnikant Sharma et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Effect of the meropenem MIC on the killing activity of meropenem and polymyxin B in combination against KPC-producing Klebsiella pneumoniae

(2017) Brandon Kulengowski et al.   JOURNAL OF ANTIBIOTICS

Pharmacodynamics of colistin and fosfomycin: a ‘treasure trove’ combination combats KPC-producing Klebsiella pneumoniae

(2017) Miao Zhao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity

(2017) Justin R. Lenhard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increased activity of colistin in combination with amikacin against Escherichia coli co-producing NDM-5 and MCR-1

(2017) Yu-Feng Zhou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and bla NDM-5 : Preparation for a Postantibiotic Era

(2017) Zackery P. Bulman et al.   mBio

In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae

(2017) Wei Yu et al.   Frontiers in Cellular and Infection Microbiology

Antibacterial activity of human simulated epithelial lining fluid concentrations of amikacin inhale alone and in combination with meropenem against Acinetobacter baumannii

(2017) Islam M. Ghazi et al.   Infectious Diseases

Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs

(2016) P. Gagetti et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Polymyxin B in Combination with Rifampin and Meropenem against Polymyxin B-Resistant KPC-Producing Klebsiella pneumoniae

(2016) John Diep et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B

(2016) Yiying Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VivoandIn VitroEfficacy of Minocycline-Based Combination Therapy for Minocycline-Resistant Acinetobacter baumannii

(2016) Ya-Sung Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model

(2016) Yiying Cai et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative pharmacodynamics of four different carbapenems in combination with polymyxin B against carbapenem-resistant Acinetobacter baumannii

(2016) Justin R. Lenhard et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model

(2016) Xiaofen Liu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Combinatorial pharmacodynamics of polymyxin B and tigecycline against heteroresistant Acinetobacter baumannii

(2016) Gauri G. Rao et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii : pharmacodynamics of new dosing strategies

(2016) Gauri G. Rao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance inAcinetobacter baumannii

(2016) Justin R. Lenhard et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Postantibiotic effect of colistin alone and combined with vancomycin or meropenem againstAcinetobacterspp. with well defined resistance mechanisms

(2016) Branka Bedenić et al.   JOURNAL OF CHEMOTHERAPY

Determination of synergy between sulbactam, meropenem and colistin in carbapenem-resistantKlebsiella pneumoniaeandAcinetobacter baumanniiisolates and correlation with the molecular mechanism of resistance

(2016) Shakti Laishram et al.   JOURNAL OF CHEMOTHERAPY

Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-ResistantKlebsiella pneumoniae: AnIn VitroModel Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time–Kill Method

(2016) Maria Lina Mezzatesta et al.   Microbial Drug Resistance

The role of doxycycline in the therapy of multidrug-resistant E. coli – an in vitro study

(2016) Chih-Cheng Lai et al.   Scientific Reports

Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?

(2016) Valerio Del Bono et al.   Virulence

Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms

(2016) Gleice Cristina Leite et al.   PLoS One

Novel Approach To Optimize Synergistic Carbapenem-Aminoglycoside Combinations against Carbapenem-Resistant Acinetobacter baumannii

(2015) Rajbharan Yadav et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacodynamics of Various Antibiotics in Combination against Extensively Drug-Resistant Klebsiella pneumoniae

(2015) Tze-Peng Lim et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections

(2015) Lynette M. Phee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivities of Novel Antimicrobial Combinations against Extensively Drug-Resistant Acinetobacter baumannii

(2015) J. Córdoba et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroActivity of Polymyxin B plus Imipenem, Meropenem, or Tigecycline against KPC-2-Producing Enterobacteriaceae with High MICs for These Antimicrobials

(2015) Natália Barth et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments

(2015) Mahableshwar S. Albur et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro synergy of polymyxins with other antibiotics for Acinetobacter baumannii: A systematic review and meta-analysis

(2015) Wentao Ni et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vivo activity of daptomycin/colistin combination therapy in a Galleria mellonella model of Acinetobacter baumannii infection

(2015) Haifei Yang et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam

(2015) Renu Singh et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Synergistic killing of NDM-producing MDRKlebsiella pneumoniaeby two ‘old’ antibiotics—polymyxin B and chloramphenicol

(2015) Nusaibah Abdul Rahim et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitroevaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae

(2015) Laurent Poirel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activities of colistin, tigecycline and tobramycin, alone or in combination, against carbapenem-resistant Enterobacteriaceae strains

(2015) Berna Ozbek et al.   Journal of Global Antimicrobial Resistance

Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: a molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations

(2015) Jocelyn Teo et al.   Antimicrobial Resistance and Infection Control

Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

(2014) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Doripenem, Gentamicin, and Colistin, Alone and in Combinations, against Gentamicin-Susceptible, KPC-Producing Klebsiella pneumoniae Strains with VariousompK36Genotypes

(2014) Cornelius J. Clancy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evaluation of Double- and Triple-Antibiotic Combinations for VIM- and NDM-Producing Klebsiella pneumoniae byIn VitroTime-Kill Experiments

(2014) T. Tängdén et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems

(2014) George L. Daikos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Time–kill effect of levofloxacin on multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: synergism with imipenem and colistin

(2014) A. Safarika et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Synergistic efficacy of meropenem and rifampicin in a murine model of sepsis caused by multidrug-resistant Acinetobacter baumannii

(2014) Yuan Sun et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model

(2014) J. Lora-Tamayo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Combination therapy for carbapenem-resistant Gram-negative bacteria

(2014) M. Paul et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitroactivity of tigecycline in combination with cefoperazone–sulbactam against multidrug-resistantAcinetobacter baumannii

(2014) Bin Liu et al.   JOURNAL OF CHEMOTHERAPY

Characterization of Porin Expression in Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniae Identifies Isolates Most Susceptible to the Combination of Colistin and Carbapenems

(2013) Jae H. Hong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Systematic Review and Meta-Analysis ofIn VitroSynergy of Polymyxins and Carbapenems

(2013) Oren Zusman et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacodynamics of Polymyxin B and Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii

(2013) Mao Hagihara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2013) Hee Ji Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutations of theompK36Porin Gene and Promoter Impact Responses of Sequence Type 258, KPC-2-Producing Klebsiella pneumoniae Strains to Doripenem and Doripenem-Colistin

(2013) Cornelius J. Clancy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroResponses of Acinetobacter baumannii to Two- and Three-Drug Combinations following Exposure to Colistin and Doripenem

(2013) Louise M. Oleksiuk et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of non-bactericidal concentrations of polymyxin B in combination with other antimicrobials against OXA-23-producing carbapenem-resistant Acinetobacter baumannii

(2013) Bárbara Netto et al.   Brazilian Journal of Infectious Diseases

Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial

(2013) Emanuele Durante-Mangoni et al.   CLINICAL INFECTIOUS DISEASES

Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptibleAcinetobacter baumanniiisolates from nosocomial pneumonia patients

(2013) Anne Marie Queenan et al.   JOURNAL OF CHEMOTHERAPY

In Vitro Activity of Doripenem in Combination with Various Antimicrobials Against Multidrug-Resistant Acinetobacter baumannii: Possible Options for the Treatment of Complicated Infection

(2013) Luigi Principe et al.   Microbial Drug Resistance

The Combination of Colistin and Doripenem Is Synergistic against Klebsiella pneumoniae at Multiple Inocula and Suppresses Colistin Resistance in anIn VitroPharmacokinetic/Pharmacodynamic Model

(2012) Zakuan Z. Deris et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Combination of Doripenem and Colistin Is Bactericidal and Synergistic against Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae

(2012) Meredith G. Jernigan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy

(2012) M. Tumbarello et al.   CLINICAL INFECTIOUS DISEASES

Systematic discovery of synergistic novel antibiotic combinations targeting multidrug-resistant Acinetobacter baumannii

(2012) Sidharth Chopra et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii

(2012) Esmeray Mutlu Yilmaz et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacodynamics of β-Lactamase Inhibition by NXL104 in Combination with Ceftaroline: Examining Organisms with Multiple Types of β-Lactamases

(2011) Arnold Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniae

(2011) Catharine C. Bulik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model

(2011) Phillip J. Bergen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients

(2011) Wang Liang et al.   BMC INFECTIOUS DISEASES

Efficacy of rifampin, in monotherapy and in combinations, in an experimental murine pneumonia model caused by panresistant Acinetobacter baumannii strains

(2011) M. E. Pachón-Ibáñez et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

(2011) Kyong Ran Peck et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In-Vitro Activity of Polymyxin B, Rifampicin, Tigecycline Alone and in Combination against Carbapenem-Resistant Acinetobacter baumannii in Singapore

(2011) Tze-Peng Lim et al.   PLoS One

Synergy Testing by Etest, Microdilution Checkerboard, and Time-Kill Methods for Pan-Drug-Resistant Acinetobacter baumannii

(2010) M. M. Sopirala et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumannii

(2010) M. E. Pachon-Ibanez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii

(2010) Glenn A. Pankuch et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units

(2010) Berna Özbek et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including  -Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

(2009) C. Vidaillac et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

“ToxRTool”, a new tool to assess the reliability of toxicological data

(2009) Klaus Schneider et al.   TOXICOLOGY LETTERS

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

(2009) Luigi Principe et al.   Annals of Clinical Microbiology and Antimicrobials

In Vitro Activity of Tigecycline against Multidrug-Resistant Acinetobacter baumannii and Selection of Tigecycline-Amikacin Synergy

(2008) E. S. Moland et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

In vitro synergism of β-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa

(2008) Kyriaki Kanellakopoulou et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS